• Cardiology, Diabetes & Nephrology
    • Cardiology, Diabetes & Nephrology – London
    • Cardiology, Diabetes & Nephrology – Brazil
    • Cardiology, Diabetes & Nephrology – Canada
    • Cardiology, Diabetes & Nephrology – USA
    • Hatter Horizon Series
    • The 18th Malvern Diabetic Foot Conference
    • Previous Events
      • CDNATL 2019 – London
      • CDNATL 2019 – Brazil
      • CDNATL 2018
      • CDNATL 2017
      • CDNATL 2016
      • CDNATL 2015
      • CDNATL 2014
      • CDATL 2013
      • CDATL 2012
      • NATL 2012
      • CDATL 2011
      • CDATL 2010
      • NATL 2010
      • CATL 2009
      • NATL 2009
  • Oncology
    • Cell Therapy at the Limits 2020
    • UCL Frontiers of Oncology 2019
      • Haematology
      • Melanoma
      • Urology
      • Women’s Health
      • Lung Cancer
      • Gastrointestinal Oncology
      • Paediatric Oncology
      • Supporters
    • Previous Events
      • Accelerating Cancer Immunotherapy 2017
        • Introduction
        • Programme
        • Chairs
        • Venue
        • Sponsor Packages
        • Supporters
      • Oncology at the Limits 2017
        • Introduction
        • Chairs
        • Programme
        • Schedule
        • Venue
        • Hotel
        • Information
        • Supporters
        • OATL 2017: Login
      • OATL 2016
      • OATL 2015
      • OATL 2014
      • OATL 2012
      • OATL 2011
      • OATL 2010
  • Multiple Sclerosis
    • Multiple Sclerosis at the Limits 2020
    • Multiple Sclerosis Nurses at the Limits 2020
    • Previous Events
      • Multiple Sclerosis Nurses at the Limits 2019
        • Introduction
        • Express Interest in MSNATL 2020
        • Programme
        • Chairs
        • Venue
        • Hotel
        • Information
        • Conflict of Interest Forms
        • Supporters
      • MSATL 2018: Introduction
        • MSATL 2018: Programme
        • MSATL 2018: Chairs
        • MSATL 2018: Schedule
        • MSATL 2018: Venue
        • MSATL 2018: Hotel
        • MSATL 2018: Information
        • MSATL 2018: CME Accreditation
        • MSATL 2018: Supporters
        • MSATL 2018: Conflict of Interest Forms
      • MSATL 2017: Introduction
        • MSATL 2017: Chairs
        • MSATL 2017: Schedule
        • MSATL 2017: Programme
        • MSATL 2017: Venue
        • MSATL 2017: Supporters
  • About
    • Academic Founders
    • Independence
    • The Lancet
    • Support & Sponsorship
    • Delegate Invitations
  • Register Interest
  • Archive
    • CDNATL 2019 – London
    • CDNATL 2019 – Brazil
    • Multiple Sclerosis Nurses at the Limits 2019
    • Hatter Horizon Series 2018
    • Multiple Sclerosis at the Limits 2018
    • Cardiology, Diabetes & Nephrology at the Limits 2018
    • Hatter Horizon Series 2017
    • Accelerating Cancer Immunotherapy 2017
    • Oncology at the Limits 2017
  • Supporters

Academic Founders

Professor Derek Yellon

Derek M Yellon PhD, DSc, FRCP (Hon), FACC, FESC, FAHA, is Professor of Molecular & Cellular Cardiology at University College London (UCL) and Director of the Hatter Cardiovascular Institute & Head of the Centre for Cardiology at UCL Hospitals & Medical School. He is also Head of the Research Department for Cardiovascular Medicine at UCL

In 1993 he was appointed Professor of Molecular & Cellular Cardiology at University College London. He is a Fellow of the Royal College of Physicians; the American College of Cardiology; the European Society of Cardiology; the International Society for Heart Research and the American Heart Association.

In 1994 he was awarded a DSc for his substantial contribution to the knowledge of cardiovascular disease and treatment. He is Vice President of the British Cardiovascular Society and is past Chairman of the Cellular Biology Working Group of the European Society of Cardiology as well as past member of the World Council of the International Society for Heart Research and the Council of the British Cardiovascular Society.

Professor Yellon was instrumental in establishing a second Hatter Cardiovascular Institute at the Medical School of the University of Cape Town to which he is also a Director and Chairman of the Institute Board. In recognition of these achievements he was in 1997, awarded an Hon Chair in the Department of Medicine at the University of Cape Town.

He is on the editorial board of a number of major Cardiovascular Journals and has published in excess of 350 full papers and edited 17 books. His main interest include, myocardial protection, the pathophysiology of cardioprotection in setting of diabetes, ischaemia/reperfusion injury, molecular aspects of adaptation to ischaemic injury and myocardial pre and postconditioning in both the basic and clinical arena.

 

Professor Lionel Opie

Lionel H. Opie, MD, DPhil, DSc, FRCP is a Professor of Medicine and the Director of the Hatter Institute for Cardiovascular Research at the University of Cape Town. After graduating from the University of Cape Town, he studied at Oxford as a Rhodes Scholar and was a Research Fellow at Harvard from 1959-1961. He was Visiting Professor (1984-1998), Division of Cardiovascular Medicine, Stanford University Medical Centre, Stanford University, California. With Richard Bing, he established the Journal of Cellular and Molecular Cardiology.

He became a Life Fellow of the University of Cape Town in 1976. From 1976-1978, he was President of the International Society for Heart Research. In 1997 he was Visiting Research Fellow, Merton College, Oxford and the Department of Physiology, University of Oxford, England. During this period he completed his single author book, Heart Physiology, from Cell to Circulation, now in its 4th Edition, Lippincott Williams and Wilkins, 2004. His major book, Drugs for the Heart, Elsevier, was first published as six articles in The Lancet and is now in its 7th edition. He is a recipient of the highest Presidential award in South Africa, The Order of Mapungubwe, for national and international contributions to cardiology.

 

 

Hatter Horizon GP Meeting
Tuesday, 3 December 2019
London, UK

Hatter Horizon Series
Monday, 9 December 2019
London, UK

Multiple Sclerosis Nurses at the Limits
Friday, 10 & Saturday, 11 January 2020, London, UK

Multiple Sclerosis at the Limits
Thursday, 23 & Friday, 24 January 2020, London, UK

Frontiers of Oncology: Colorectal Cancer
February 2020, London, UK

Cardiology, Diabetes & Nephrology at the Limits 2020
Monday, 20 - Wednesday, 22 April 2020, London, UK

Cell Therapy at the Limits 2020
Thursday, 21 - Friday, 22 May 2020, London, UK

The 18th Malvern Diabetic Foot Conference
Wednesday, 13 - Friday, 15 May 2020, Malvern, UK

Cardiology, Diabetes & Nephrology at the Limits Brazil
Friday, 17 - Saturday, 18 July 2020, São Paulo, Brazil

Cardiology, Diabetes & Nephrology at the Limits Canada
Monday, 4 - Tuesday, 5 May 2020, Toronto, Canada

  • Contact
  • The Lancet
  • UCL
  • UCT
  • Brigham & Women’s Hospital
  • The University of Campinas
  • Medical Disclaimer
  • Disclosure
  • E-mail Policy
  • Privacy Policy
  • Anti-spam Policy
  • Disclaimer
  • External Links Policy
  • Terms of use
  • Contact
  • The Lancet
  • UCL
  • UCT
  • Brigham & Women’s Hospital
  • The University of Campinas
© 2019 At the Limits Ltd.
This site uses cookies More info